Amanote Research
Register
Sign In
Ibandronate in the Treatment of Pediatric Osteoporosis
Bone Abstracts
doi 10.1530/boneabs.3.pp409
Full Text
Open PDF
Abstract
Available in
full text
Date
May 1, 2014
Authors
Stepan Kutilek
Ivana Plasilova
Publisher
Bioscientifica
Related search
Clinical Efficacy and Safety of Monthly Oral Ibandronate 100 Mg Versus Monthly Intravenous Ibandronate 1 Mg in Japanese Patients With Primary Osteoporosis
Osteoporosis International
Medicine
Endocrinology
Metabolism
Diabetes
Dose-Response Study of Ibandronate in the Treatment of Cancer-Associated Hypercalcaemia
British Journal of Cancer
Cancer Research
Oncology
Treatment of Osteoporosis.
BMJ
The Diagnosis and Treatment of Osteoporosis
Yeungnam University Journal of Medicine
National Trends in Osteoporosis Visits and Osteoporosis Treatment, 1988-2003
Archives of Internal Medicine
The Role of Hormone Therapy in the Treatment of Osteoporosis
Journal of Endocrinology, Metabolism and Diabetes of South Africa
Internal Medicine
Endocrinology
Metabolism
Diabetes
The Implementation of Personalized Treatment for Osteoporosis
Japanese Journal of Geriatrics
Gerontology
Geriatrics
Treatment Options for Osteoporosis
Mayo Clinic Proceedings
Medicine
Denosumab – A New Medication in the Treatment of Postmenopausal Osteoporosis
Przeglad Menopauzalny
Gynecology
Endocrinology
Metabolism
Obstetrics
Diabetes